India Plasma Fractionation Market Size Likely to Expand at a CAGR of 4.1% By 2033

India Plasma Fractionation Market size was valued at USD 352.6 Million in 2024 and is expected to reach USD 498.2 Million by 2033, at a CAGR of 4.1% during the forecast period 2024 – 2033.

India Plasma Fractionation Market: Overview

Plasma fractionation is a process used to separate various components of blood plasma, the liquid portion of blood, into its constituent parts. This process involves fractionating or dividing plasma into its proteins and other components through a series of biochemical and physical separation techniques.

In the Indian plasma fractionation industry, a notable trend is the increasing focus on self-sufficiency and technological advancements to meet the growing demand for plasma-derived products. This trend stems from the country’s efforts to reduce dependence on imported plasma-based therapies and ensure a stable supply chain for critical medical treatments.

To achieve this, there’s a rising emphasis on expanding domestic plasma collection infrastructure, including plasma donation centers and plasma fractionation facilities. Moreover, advancements in plasma fractionation technology, such as improved purification techniques and process automation, are enhancing efficiency and product quality while reducing production costs.

Additionally, there’s a growing interest in research and development initiatives aimed at developing novel plasma-derived therapies tailored to address specific medical needs prevalent in the Indian population. Overall, these trends reflect a shift towards greater self-reliance and innovation within India’s plasma fractionation industry, poised to positively impact healthcare accessibility and affordability in the country.

By product, the immunoglobulin segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. One significant trend in immunoglobulin therapy is the increasing demand and usage, driven by rising awareness and diagnosis of immunodeficiency disorders, autoimmune diseases, and neurological conditions like CIDP and Guillain-Barré syndrome.

This surge in demand underscores the importance of ensuring a stable and sustainable supply of immunoglobulin products to meet patient needs.

By application, the immunology & neurology segment held the highest market share in 2023 and is expected to keep its dominance during the forecast period 2024-2033. In immunology, personalized medicine approaches are gaining traction, tailoring treatments to individual immune profiles.

Meanwhile, in neurology, there’s a growing focus on neuroinflammation’s role in various conditions, leading to novel therapies targeting the immune system within the central nervous system to tackle neurodegenerative diseases like Alzheimer’s and multiple sclerosis.

In West India, a notable trend is the burgeoning adoption of telemedicine and digital health solutions, driven by factors such as urbanization, technological advancements, and the need for accessible healthcare. This trend is transforming healthcare delivery, enabling remote consultations, personalized care, and health monitoring, especially in densely populated urban centers.

Reliance Life Sciences is a medical biotechnology-led company engaged in the research and development, manufacturing and marketing of differentiated medical products and services, used to treat patients primarily in intensive and critical care units in hospitals.

T The major key players in India Plasma Fractionation market are PlasmaGen BioSciences Pvt. Ltd., Reliance Life Sciences, Biocon Limited, Intas Pharmaceuticals Ltd., Bharat Serums and Vaccines Limited, VIRCHOW BIOTECH, Fusion Healthcare, Kedrion S.p.A, Hemarus. and Others.

Report Scope

CMI has comprehensively analyzed India’s Plasma Fractionation market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict an in-depth scenario of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this India Plasma Fractionation industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

List of the prominent players in the India Plasma Fractionation Market:

• PlasmaGen BioSciences Pvt. Ltd.
• Reliance Life Sciences
• Biocon Limited
• Intas Pharmaceuticals Ltd.
• Bharat Serums and Vaccines Limited
• VIRCHOW BIOTECH
• Fusion Healthcare
• Kedrion S.p.A
• Hemarus
• Others

The India Plasma Fractionation Market is segmented as follows:

By Product

• Albumin
• Immunoglobulin
• Coagulation Factors
• Others

By Application

• Immunology & Neurology
• Haematology
• Critical Care
• Pulmonology
• Others

By Method

• Centrifugation
• Depth Filtration
• Chromatography
• Others

By End Use

• Hospitals & Clinics
• Clinical Research
• Others